Register entry
Viyash Life Sciences Private Limited
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 46
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
4646 active NDC listings: 46 bulk ingredient. By marketing category: BULK INGREDIENT 46.
| Dosage form | NDCs |
|---|---|
| powder | 45 |
| liquid | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| viyash life sciences private limited | 46 |
Catalogue
Marketed products
46| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | ABACAVIR SULFATE | powder | 82245-0207BULK INGREDIENT |
| - | Apixaban | powder | 82245-0126BULK INGREDIENT |
| - | BACLOFEN | powder | 82245-0205BULK INGREDIENT |
| - | Bosentan | powder | 82245-0104BULK INGREDIENT |
| - | Clomiphene Citrate | powder | 82245-0214BULK INGREDIENT |
| - | Dapagliflozin Propanediol Monohydrate | powder | 82245-0213BULK INGREDIENT |
| - | Deucravacitinib | powder | 82245-0218BULK INGREDIENT |
| - | Dimethyl Fumarate | powder | 82245-0105BULK INGREDIENT |
| - | Dolutegravir Sodium | powder | 82245-0202BULK INGREDIENT |
| - | Edoxaban Tosylate Monohydrate | powder | 82245-0219BULK INGREDIENT |
| - | Epinephrine | powder | 82245-0116BULK INGREDIENT |
| - | Epinephrine Bitartrate | powder | 82245-0115BULK INGREDIENT |
| - | FEBUXOSTAT | powder | 82245-0103BULK INGREDIENT |
| - | Finerenone | powder | 82245-0216BULK INGREDIENT |
| - | Fingolimod Hydrochloride | powder | 82245-0106BULK INGREDIENT |
| - | Formoterol Fumarate Dihydrate | powder | 82245-0113BULK INGREDIENT |
| - | Frovatriptan Succinate | powder | 82245-0110BULK INGREDIENT |
| - | Glycopyrrolate | powder | 82245-0121BULK INGREDIENT |
| - | Ivacaftor | powder | 82245-0123BULK INGREDIENT |
| - | Labetalol Hydrochloride | powder | 82245-0203BULK INGREDIENT |
| - | Lacosamide | powder | 82245-0209BULK INGREDIENT |
| - | Lamivudine | powder | 82245-0204BULK INGREDIENT |
| - | Lenalidomide | powder | 82245-0101BULK INGREDIENT |
| - | Linagliptin | powder | 82245-0124BULK INGREDIENT |
| - | Losartan Potassium | powder | 82245-0208BULK INGREDIENT |
| - | Macitentan | powder | 82245-0117BULK INGREDIENT |
| - | Mavacamten | powder | 82245-0215BULK INGREDIENT |
| - | Nilotinib Premix | powder | 82245-0220BULK INGREDIENT |
| - | Niraparib Tosylate Monohydrate | powder | 82245-0217BULK INGREDIENT |
| - | OLMESARTAN MEDOXOMIL | powder | 82245-0206BULK INGREDIENT |
| - | Palbociclib | powder | 82245-0111BULK INGREDIENT |
| - | Pomalidomide | powder | 82245-0108BULK INGREDIENT |
| - | Pramipexole Dihydrochloride | powder | 82245-0120BULK INGREDIENT |
| - | Prasugrel Hydrochloride | powder | 82245-0102BULK INGREDIENT |
| - | Proguanil Hydrochloride | powder | 82245-0109BULK INGREDIENT |
| - | Rasagiline Mesylate | powder | 82245-0114BULK INGREDIENT |
| - | Rivastigmine | liquid | 82245-0107BULK INGREDIENT |
| - | Roflumilast | powder | 82245-0118BULK INGREDIENT |
| - | Rotigotine | powder | 82245-0112BULK INGREDIENT |
| - | Saxagliptin Hydrocloride Dihydrate | powder | 82245-0119BULK INGREDIENT |
| - | Sertraline Hydrochloride (Form-II) | powder | 82245-0211BULK INGREDIENT |
| - | Tenofovir Disoproxil Fumarate | powder | 82245-0201BULK INGREDIENT |
| - | Ticagrelor | powder | 82245-0122BULK INGREDIENT |
| - | Vilazodone Hydrochloride | powder | 82245-0125BULK INGREDIENT |
| - | Viloxazine Hydrochloride | powder | 82245-0212BULK INGREDIENT |
| - | Vonoprazan Fumarate | powder | 82245-0210BULK INGREDIENT |
Compare
Other companies listing abacavir sulfate
- Viyash Scientific Limited9 sites · 58 NDC
- Matrix Pharmacorp Private Limited5 sites · 122 NDC
Enquiry
Common questions
- Is Viyash Life Sciences Private Limited FDA approved?
- Viyash Life Sciences Private Limited holds no registered establishment of its own; 46 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Viyash Life Sciences Private Limited make?
- 46 products are listed under Viyash Life Sciences Private Limited in the openFDA NDC Directory, most often as powder; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.